The most cited reference was Hershman DL’s paper, which was a randomized clinical trial (RCT) of the acupuncture effects on joint pain related to aromatase inhibitors among women with early-stage breast cancer, published in JAMA in 2018. Here, CYP19A1 is linked to breast carcinoma.